Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2013 1
2014 1
2016 1
2017 1
2020 2
2021 1
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J, Papasidero S, Medina MA, Klajn D, Chaparro Del Moral R, Rillo O, Martiré V, Crespo G, Secco A, Catalan Pellet A, Amitrano C, Crow C, Asnal C, Pucci P, Caeiro F, Benzanquen N, Pirola JP, Mayer M, Zazzetti F, Velez S, Barreira J, Tamborenea N, Santiago L, Raiti L. Demarchi J, et al. Among authors: zazzetti f. Clin Rheumatol. 2017 Nov;36(11):2455-2460. doi: 10.1007/s10067-017-3822-3. Epub 2017 Sep 14. Clin Rheumatol. 2017. PMID: 28913747
Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort.
Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA. Ugarte-Gil MF, et al. Among authors: zazzetti f. Lupus Sci Med. 2022 Mar;9(1):e000641. doi: 10.1136/lupus-2021-000641. Lupus Sci Med. 2022. PMID: 35351811 Free PMC article.
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA. Ugarte-Gil MF, et al. Among authors: zazzetti f. Lupus Sci Med. 2022 Feb;9(1):e000616. doi: 10.1136/lupus-2021-000616. Lupus Sci Med. 2022. PMID: 35193948 Free PMC article.
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Ritchlin CT, Helliwell PS, Boehncke WH, Soriano ER, Hsia EC, Kollmeier AP, Chakravarty SD, Zazzetti F, Subramanian RA, Xu XL, Zuraw QC, Sheng S, Jiang Y, Agarwal P, Zhou B, Zhuang Y, Shawi M, Karyekar CS, Deodhar A. Ritchlin CT, et al. Among authors: zazzetti f. RMD Open. 2021 Feb;7(1):e001457. doi: 10.1136/rmdopen-2020-001457. RMD Open. 2021. PMID: 33568556 Free PMC article. Clinical Trial.
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study.
Ritchlin CT, Deodhar A, Boehncke WH, Soriano ER, Kollmeier AP, Xu XL, Zazzetti F, Shawi M, Jiang Y, Sheng S, Helliwell PS. Ritchlin CT, et al. Among authors: zazzetti f. ACR Open Rheumatol. 2023 Mar;5(3):149-164. doi: 10.1002/acr2.11523. Epub 2023 Feb 10. ACR Open Rheumatol. 2023. PMID: 36762512 Free PMC article.
Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America.
Alves Pereira I, Maldonado Cocco J, Feijó Azevedo V, Guerra G, Bautista-Molano W, Casasola JC, Vega Morales D, Soriano ER, Gil DR, Zazzetti F, Aldunate L, Holdsworth EA, Massey O, Lobosco S, Lawson F. Alves Pereira I, et al. Among authors: zazzetti f. Clin Rheumatol. 2020 Jun;39(6):1813-1822. doi: 10.1007/s10067-019-04858-x. Epub 2020 Feb 7. Clin Rheumatol. 2020. PMID: 32030635
Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.
Collado MV, Dorado E, Rausch S, Gomez G, Khoury M, Zazzetti F, Gargiulo M, Suarez L, Chaparro R, Paira S, Galvan L, Juarez V, Pisoni C, Garcia M, Martinez L, Alvarez A, Alvarez C, Barreira J, Sarano J. Collado MV, et al. Among authors: zazzetti f. J Clin Rheumatol. 2016 Sep;22(6):299-306. doi: 10.1097/RHU.0000000000000395. J Clin Rheumatol. 2016. PMID: 27152693 Free PMC article.
14 results